Plunkett Research Online: ImmunoCellular Therapeutics Limited

IMMUNOCELLULAR THERAPEUTICS LIMITED (IMUC:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ImmunoCellular Therapeutics Ltd is a US-based clinical-stage biotechnology company. It is engaged in developing immune-based therapies for the treatment of cancers which can elicit an immune response against several antigens. The company has developed ICT-107, which is a dendritic cell (DC) immunoth.....



ImmunoCellular Therapeutics Limited
Ticker: IMUC
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 818 992-2907
Fax:
Address: 30721 Russell Ranch Road
Suite 140
Westlake Village, CA 91362 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Surgical and Medical Instrument (Medical Devices) Manufacturing
ContactsDescription
David FractorCFO
Gary TitusChairman of the Board/Director/Secretary
See More
ImmunoCellular Therapeutics Ltd is a US-based clinical-stage biotechnology company. It is engaged in developing immune-based therapies for the treatment of cancers which can elicit an immune response against several antigens. The company has developed ICT-107, which is a dendritic cell (DC) immunoth.....See More See More

Auditor: Marcum LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: